Does empagliflozin modulate the autonomic nervous system among individuals with type 2 diabetes and coronary artery disease? The EMPA-HEART CardioLink-6 Holter analysis

Does empagliflozin modulate the autonomic nervous system among individuals with type 2 diabetes and coronary artery disease? The EMPA-HEART CardioLink-6 Holter analysis

Context: We examined if empagliflozin was associated with modulation of cardiac autonomic tone among subjects with type 2 diabetes and stable coronary artery disease (CAD) relative to placebo. Methods: Using ambulatory 24-h Holter electrocardiographic data prospectively collected from a randomized t...

Full description

Bibliographic Details
Main Authors: Vinay Garg, Subodh Verma, Kim A. Connelly, Andrew T. Yan, Aditya Sikand, Ankit Garg, Paul Dorian, Fei Zuo, Lawrence A. Leiter, Bernard Zinman, Peter Jüni, Atul Verma, Hwee Teoh, Adrian Quan, C. David Mazer, Andrew C.T. Ha
Format: Article
Language:English
Published: Elsevier 2020-09-01
Series:Metabolism Open
Online Access:http://www.sciencedirect.com/science/article/pii/S2589936820300190

Internet

http://www.sciencedirect.com/science/article/pii/S2589936820300190

Similar Items